STEMINENT BIOTHERAPEUTICS INCSTEMINENT BIOTHERAPEUTICS INCSTEMINENT BIOTHERAPEUTICS INC

STEMINENT BIOTHERAPEUTICS INC

No trades
See on Supercharts

7729 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Steminent Biotherapeutics, Inc. develops novel cellular therapeutics and engages in the research and development of new stem cell drugs. Its products include stemchymal, stemchymal therapeutic advantages and stemchymal application fields. The company was founded on December 18, 2007 and is headquartered in Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
7729 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company